Below are the earnings highlights for Jazz Pharmaceuticals plc (JAZZ):
Earnings: -$718.47 million in Q2 vs. $168.57 million in the same period last year. EPS: -$11.74 in Q2 vs. $2.49 in the same period last year. Excluding items, Jazz Pharmaceuticals plc reported adjusted earnings of -$504.85 million or -$8.25 per share for the period.
Revenue: $1.045 billion in Q2 vs. $1.023 billion in the same period last year.
-Guidance:Full year EPS guidance: $4.80 - $5.60Full year revenue guidance: $4,150 - $4,300 Mln
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.